Research output

  1. Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC) (Annals of Surgical Oncology, (2022), 29, 6, (3694-3708), 10.1245/s10434-021-11236-y)

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  2. Single agent Talimogene Laherparepvec for stage IIIB-IVM1c melanoma patients: A systematic review and meta-analysis

    Research output: Contribution to journal › Review article › Academic › peer-review

  3. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

    Research output: Contribution to journal › Article › Academic › peer-review

View all (5) »

ID: 21298865